Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
QurAlis to Participate in Upcoming Investor Conferences in February | ||||||||||||||
By: PR Newswire Association LLC. - 05 Feb 2024 | Back to overview list |
|||||||||||||
CAMBRIDGE, Mass., Feb. 5, 2024 /PRNewswire/ -- QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that will alter the trajectory of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative diseases, today announced that Kasper Roet, Ph.D., CEO and co-founder, will present a corporate overview at the following investor conferences in February.
The QurAlis corporate presentation can be accessed by visiting the presentations section of the Company's website at www.quralis.com. About QurAlis Corporation View original content to download multimedia:https://www.prnewswire.com/news-releases/quralis-to-participate-in-upcoming-investor-conferences-in-june-302052681.html SOURCE QurAlis |
||||||||||||||
|
||||||||||||||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |